ClinVar Miner

Submissions for variant NM_000138.5(FBN1):c.5442C>T (p.Asn1814=)

gnomAD frequency: 0.00004  dbSNP: rs397515822
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 15
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000035226 SCV000058871 likely benign not specified 2008-03-01 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000397998 SCV000392296 likely benign Weill-Marchesani syndrome 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000303570 SCV000392297 likely benign Geleophysic dysplasia 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000355990 SCV000392298 likely benign Acromicric dysplasia 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000263353 SCV000392299 likely benign Ectopia lentis 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000297465 SCV000392300 likely benign Marfan syndrome 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000354690 SCV000392301 likely benign MASS syndrome 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000276436 SCV000392302 likely benign Familial thoracic aortic aneurysm and aortic dissection 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000330003 SCV000392303 likely benign Stiff skin syndrome 2016-06-14 criteria provided, single submitter clinical testing
GeneDx RCV000589101 SCV000520906 likely benign not provided 2021-02-01 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000589101 SCV000695559 benign not provided 2016-05-02 criteria provided, single submitter clinical testing Variant summary: The c.5442C>T (p.Asn1814=) in FBN1 gene is a synonymous change that involves a non-conserved nucleotide. 5/5 in silico programs in Alamut predict that this variant does not affect normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in the control population dataset of ExAC at frequency of 0.00014 (18/121254 chrs tested), which exceeds the maximal expected frequency of a pathogenic allele (0.000125) in this gene. The variant of interest was cited as Likely Benign by reputable database/clinical laboratory. Taking together, the variant was classified as Benign.
Color Diagnostics, LLC DBA Color Health RCV000276436 SCV000913674 likely benign Familial thoracic aortic aneurysm and aortic dissection 2018-07-23 criteria provided, single submitter clinical testing
Invitae RCV001468352 SCV001672395 likely benign Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection 2024-01-03 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV000276436 SCV002041998 likely benign Familial thoracic aortic aneurysm and aortic dissection 2020-03-18 criteria provided, single submitter clinical testing
Ambry Genetics RCV000276436 SCV002652267 likely benign Familial thoracic aortic aneurysm and aortic dissection 2017-12-27 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.